Atamestane
Atamestane has been studied in 1 paper since 2006: 1 trial in people. The newest paper, Jun 27, 2006: “Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men”.
“There were no differences between the treatment arms and placebo group in any of the outcome measurements after intervention.”
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave atamestane to people and measured what changed.
no change: Has no effect on physical frailty
Randomized trial83 peopleMen70 yr and over36 wk
Older adults; with low scores on strength tests
The Journal of clinical endocrinology and metabolism, Jun 27, 2006
What did studies of Atamestane find?
1Studies of Atamestane measured 1 outcome; the most studied are physical frailty (1 study).
Physical frailty
no changein humans1
1 study
Physical frailty
no changein humans1
Atamestane has no effect on physical frailty in humans.
“There were no differences between the treatment arms and placebo group in any of the outcome measurements after intervention.”
Human trialwith low scores on strength tests36 wkmalesn = 83
Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men
The Journal of clinical endocrinology and metabolism